current user: public

If you have questions about the server, please let us know.

Query: PB002794 gi|86143885|ref|ZP_01062253.1| hypothetical protein MED217_03525 [Flavobacterium sp. MED217]gi|85829592|gb|EAQ48055.1| hypothetical protein MED217_03525 [Leeuwenhoekiella blandensis MED217], from HGM_OVER

Results of FFAS03 search in PfamA32U
Master-slave alignment(slide right to see more) does not show gaps in the query sequence, use ali links to display alignment between query and templates.
    .   10    .   20    .   30    .   40    .   50    .   60    .   70    .   80    .   90    .  100    .  110    .  120    .  130    .  140    .  150    .  160    .  170    .  180    .  190    .  200    .  210    .  220    .  230    .  240    .  250    .  260    .  270    .  280    .  290    .  300    .  310
# Score Template Links and tools%idFirst MNTETLTYLLEHPDKITSEETTQLRTVVEEFPFFQAARALHLKGLKNEDSFLYNTYLKKTAAHTQDRTVLFDFITSEIFNQTAISAQIKAQEDHLRNMPVHEFVDVSSEMEAEELQKANRVLDPEFFVRKEASEETQPEEQLQLGKPLDFNKAETHSFSEWLKLTAFNKIDRSKEVKETISASASDKTEASSENTIIEETASETPLELETTIPSIEVDQDPERARRLELIDKFIESNPKIKVSTPDSNFKKPNLEDRFQPSDSLMTETLARVYVEQKNFSKAKQAYRILSLKYPEKSGFFADQIRAIEKLQENLast
1 -9.020PF09295.10; Q6CDA2_YARLI/40-455; ChAPs (Chs5p-Arf1p-binding proteins)  ali follow..  15  193.....................................................................................................................................................................................................................................................................SNYLVDAFMAFMRITRLYDRGLEIVRRLQTEYPEVVSLIAEAVKTMVKGLE. 253
2 -8.940PF12583.8; B3MDE1_DROAN/1032-1170; Tripeptidyl peptidase II N terminal  ali follow..  17  50...............................................................................................................................................................................................................................................VQSDAPVENGGCPASPKKGKSNADDYAESLRDFYINKCELEMAEKIYGEVVAAHPKHLQAHLLLIQNIESSQLK 126
3 -8.870PF13512.6; Q6LMX6_PHOPR/21-165; Tetratricopeptide repeat  ali follow..  12  1................................................................................................................................................................................................................................................................TEEVVPDVPPAELAQQALQSGSWTTAIERLETLDSRYPFGAAYYKNDEATIARFNRL 76
4 -8.570PF03656.13; TIM16_CAEEL/1-135; Pam16  ali follow..  59....................................................................................................................................................................................................................................................................KLGISLEESLQILVKTPLNREEVKHYEHLFNIDKSKTLYLQSKVFRAKERIDE 116
5 -8.040PF13429.6; Q39U81_GEOMG/198-480; Tetratricopeptide repeat  ali follow..  14...........................................................................................................................................................................................................................................................................RASALTFGTGDVKGAYAILDRGRQIIPASATAYWQSFDDLAWSLQD 59
6 -7.970PF17826.1; G1SXV9_RABIT/101-469; Family of unknown function (DUF5588 topsan)  ali follow..  13  38...........................................................................................................................................................................................................................................................EETESSDDVEALTTKKFKGDLAYRQGEYQKALQEYSSIAEKLSPTNF-HQEALEIATELEN. 116
7 -7.930PF13371.6; Q1LJ97_CUPMC/200-272; Tetratricopeptide repeat  ali follow..  13  1............................................................................................................................................................................................................................................................................LKAIYLQESRWQRLLAVQNRLVILLPDSIEEVRDRLEDLEAYVQ. 57
8 -7.800PF04781.12; B3H4B1_ARATH/23-139; Protein of unknown function (DUF627 topsan)  ali follow..  15  1............................................................................................................................................................................................................................................................................LAKGYWKKGNRIEALMLTEKTISDQGKKRVYLFASLDAFSMFTL. 73
9 -7.800PF13525.6; D3V9W2_XENNA/28-237; Outer membrane lipoprotein  ali follow..  15  10...........................................................................................................................................................................................................................................................................SIGQEKLQEGNYKAAIKQLESLDNRYPFGPAYYKSAIASIDRFIRL 71
10 -7.550PF12569.8; A7S752_NEMVE/188-686; NMDA receptor-regulated protein 1  ali follow..  19  32................................................................................................................................................................................................................................................................PLICDKLAIKEVQGQIFIELGERSKAEAIYRDLIKRNPENHSYYEDRLNLYLQYNS. 99

FFAS is supported by the NIH grant R01-GM087218-01
1 3 7 8 0 7   jobs submitted since Jan 1, 2011
Comments and questions to: webmaster

Selected papers from Godzik Lab
Ying Zhang, Ines Thiele, Dana Weekes, Zhanwen Li, Lukasz Jaroszewski, Krzysztof Ginalski, Ashley Deacon, John Wooley, Scott Lesley, Ian Wilson, Bernhard Palsson, Andrei Osterman, Adam Godzik. Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima. Science. 2009 Sep 18;325(5947):1544-9.

Mayya Sedova, Mallika Iyer, Zhanwen Li, Lukasz Jaroszewski, Kai W Post, Thomas Hrabe, Eduard Porta-Pardo, Adam Godzik Cancer3D 2.0:: interactive analysis of 3D patterns of cancer mutations in cancer subsets. Nucleic Acids Research, gky1098 2018; Published on November 8 2018.

Sasin JM, Godzik A, Bujnicki JM. SURF'S UP! - protein classification by surface comparisons. J Biosci. 2007 Jan;32(1):97-100.